Luliconazole, a highly effective imidazole, against Fusarium species complexes

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Medical Microbiology and Immmunology

• Publication date

  2020-04-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00430-020-00672-4PMID 32253502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent of invasive aspergillosis.

  2019cited by this paper
• Efficacy of Luliconazole Against Broad-Range Filamentous Fungi Including Fusarium solani Species Complex Causing Fungal Keratitis

  2018cited by this paper
• Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species

  2018cited by this paper
• Luliconazole, an alternative antifungal agent against Aspergillus terreus.

  2017cited by this paper
• First description of spontaneous fungal peritonitis caused by Fusarium solani in a critically ill patient with liver cirrhosis

  2017cited by this paper
• Outbreak of Fusarium oxysporum infections in children with cancer: an experience with 7 episodes of catheter-related fungemia

  2017cited by this paper
• Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double‐blind, randomized phase III study

  2017cited by this paper
• Multidrug‐resistant Fusarium in keratitis: a clinico‐mycological study of keratitis infections in Chennai, India

  2017cited by this paper
• In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and Relatives

  2017cited by this paper
• Tavaborole, Efinaconazole, and Luliconazole: Three New Antimycotic Agents for the Treatment of Dermatophytic Fungi

  2017cited by this paper
• Epidemiological Study of Fusarium Species Causing Invasive and Superficial Fusariosis in Japan.

  2017cited by this paper
• Luliconazole, a new antifungal against Candida species isolated from different sources.

  2017cited by this paper
• Reduced Multidrug Susceptibility Profile Is a Common Feature of Opportunistic Fusarium Species: Fusarium Multi-Drug Resistant Pattern

  2017cited by this paper
• New Antifungal Agents and New Formulations Against Dermatophytes

  2017cited by this paper
• Fusarium: Molecular Diversity and Intrinsic Drug Resistance

  2016cited by this paper
• Phylogeny, diagnostics and antifungal susceptibility of clinically relevant Fusarium species

  2016cited by this paper
• Antifungal activities of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Fusarium spp.

  2016cited by this paper
• Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus Strains

  2016cited by this paper
• In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.

  2016cited by this paper
• [In vitro Antifungal Activity of Luliconazole against Trichophyton spp].

  2016cited by this paper
• Fatal Cases of Bloodstream Infection by Fusarium solani and Review of Published Literature

  2016cited by this paper
• Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review

  2016cited by this paper
• Invasive Fusariosis: A Single Pediatric Center 15-Year Experience.

  2015cited by this paper
• Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1‐year follow‐up in nine cases

  2015cited by this paper
• International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method

  2015cited by this paper
• Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study.

  2014cited by this paper
• Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.

  2014cited by this paper
• Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis.

  2014cited by this paper
• Luliconazole Demonstrates Potent In Vitro Activity against Dermatophytes Recovered from Patients with Onychomycosis

  2014cited by this paper
• A Randomized, Double-blind, Vehicle-controlled Trial of Luliconazole Cream 1% in the Treatment of Interdigital Tinea Pedis.

  2014cited by this paper
• Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance® registry

  2014cited by this paper
• Luliconazole: a review of a new antifungal agent for the topical treatment of onychomycosis

  2014cited by this paper
• Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment

  2013cited by this paper
• Safety and Tolerability of Luliconazole Solution 10-Percent in Patients with Moderate to Severe Distal Subungual Onychomycosis

  2013cited by this paper
• Increased Incidence of Invasive Fusariosis with Cutaneous Portal of Entry, Brazil

  2013cited by this paper
• Successful Medical Management of Recalcitrant Fusarium solani Keratitis: Molecular Identification and Susceptibility Patterns

  2012cited by this paper
• Short-Term Therapy with Luliconazole, a Novel Topical Antifungal Imidazole, in Guinea Pig Models of Tinea Corporis and Tinea Pedis

  2012cited by this paper
• Successful treatment of disseminated fusariosis with voriconazole in an acute lymphoblastic leukaemia patient

  2011cited by this paper
• Fusarium Infection in Lung Transplant Patients: Report of 6 Cases and Review of the Literature

  2011cited by this paper
• Current Status of Fusarium Infection in Human and Animal

  2011cited by this paper
• In vitro interactions between amphotericin B and other antifungal agents and rifampin against Fusarium spp.

  2011cited by this paper
• Role for Fks1 in the Intrinsic Echinocandin Resistance of Fusarium solani as Evidenced by Hybrid Expression in Saccharomyces cerevisiae

  2009cited by this paper
• In vitro antifungal activities of luliconazole, a new topical imidazole.

  2009cited by this paper
• Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.

  2008cited by this paper
• Activities of Antifungal Agents against Yeasts and Filamentous Fungi: Assessment according to the Methodology of the European Committee on Antimicrobial Susceptibility Testing

  2008cited by this paper
• Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.

  2007cited by this paper
• Efficacy of Topical Caspofungin in Experimental Fusarium Keratitis

  2007cited by this paper
• Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.

  2006cited by this paper
• A comparative clinical study between 2 weeks of luliconazole 1% cream treatment and 4 weeks of bifonazole 1% cream treatment for tinea pedis

  2006cited by this paper
• Human fusariosis.

  2004cited by this paper
• FUSARIUM-ID v. 1.0: A DNA Sequence Database for Identifying Fusarium

  2004cited by this paper
• Infection and Drug Resistance Dovepress a Critical Appraisal of Once-daily Topical Luliconazole for the Treatment of Superficial Fungal Infections

  year unknowncited by this paper

• Antifungal susceptibility, clinical findings, and biofilm resistance of Fusarium species causing keratitis: a challenge for disease control

  2025cites this paper
• The efficacy of luliconazole and caspofungin on planktonic and biofilm of Candida albicans from different sources

  2025influential citation
• Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China

  2023cites this paper
• Antifungal Efficacy of Luliconazole in an Experimental Rabbit Model of Fungal Keratitis Caused by Fusarium solani

  2023cites this paper
• Phase-Dependent Differential In Vitro and Ex Vivo Susceptibility of Aspergillus flavus and Fusarium keratoplasticum to Azole Antifungals

  2023cites this paper
• In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs

  2022cites this paper
• Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole

  2022cites this paper
• in vitro Activity of Seven Antifungals against Different Clinical Candida Species

  2021cites this paper
• Genotypic diversity and antifungal susceptibility pattern of Candida albicans species isolated from hospitalized paediatric patients with urinary tract infection in Iran

  2021cites this paper
• Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans

  2021cites this paper
• Molecular Identification, And Antifungal Susceptibility Patterns of Candida Species Isolated From Candidemia Patients in Yasuj, Southwestern Iran

  2021cites this paper
• Multipotentiality of Luliconazole against Various Fungal Strains: Novel Topical Formulations and Patent Review.

  2021cites this paper
• Pelvic Abscess by Fusarium fujikuroi in an Immunocompetent Woman

  2021cites this paper
• Грибковый эндофтальмит. Обзор литературы

  2020cites this paper
• Fungal Endophthalmitis. Literature Review

  2020cites this paper